PRELUDE THERAPEUTICS INC shareholders Q4 2022

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

PRELUDE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$60,639,7341.16%
Baker Brothers Advisors 10,123,824$61,147,8970.37%
GSA CAPITAL PARTNERS LLP 47,801$2890.04%
CAXTON ASSOCIATES LP 65,453$395,3360.03%
DENALI ADVISORS LLC 8,200$49,5280.02%
683 Capital Management, LLC 28,631$172,9310.02%
MIRABELLA FINANCIAL SERVICES LLP 16,058$96,9900.01%
Candriam S.C.A. 179,850$1,086,2430.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2,335,944$14,109,1020.01%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 82,000$495,2800.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,949$223,1720.01%
DARK FOREST CAPITAL MANAGEMENT LP 3,092$18,6760.01%
Bleakley Financial Group, LLC 22,325$134,8430.01%
FMR LLC 4,589,592$27,721,1350.00%
STATE OF WISCONSIN INVESTMENT BOARD 100,400$606,4160.00%
BOOTHBAY FUND MANAGEMENT, LLC 17,623$106,4430.00%
Renaissance Technologies 136,500$8240.00%
Tower Research Capital LLC (TRC) 3,532$210.00%
China Universal Asset Management Co., Ltd. 370$2,2350.00%
Cutler Group LLC / CA 2,130$120.00%
External links

This page lists PRELUDE THERAPEUTICS INC's shareholders in Q4 2022. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.